Michael M. Weinkowitz, Esquire actively practices in Pennsylvania, New Jersey and New York. His practice is national in scope and focuses primarily on complex litigation, products liability, pharmaceutical and medical device litigation and employment law. He has appeared pro hac vice in various state courts throughout the country. He is admitted to the United States District Courts, Eastern District of Pennsylvania, the District of New Jersey, the Eastern and Southern Districts of New York and United States Court of Appeals for the Third Circuit.
Michael is currently serving as co-liaison counsel in In Re: Yaz/Yasmin/Ocella Products Liability consolidated litigation in Pennsylvania. He has served on various Discovery and Science Committees including in In re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2100 (S.D. Ill.); In re: VIOXX Product Liability Litigation, MDL No. 1657 (E.D. La.). He worked as a member of the subcommittee responsible for crafting the Vioxx trial package and assisted in the negotiations, and crafting of the Settlement Agreement that led to the 4.85 Billion dollar settlement with Merck. He served as a member a joint defense and plaintiff review committee for the Vioxx Settlement Program. He has represented those injured by Pradaxa, Denture Cream, Yaz/Yasmin/Ocella, Hip Implants, Diethylstilbestrol (DES), Ortho Evra Birth Control Patch, Vioxx/Bextra/Celebrex, Fosamax, Digitek, Actos, and Cough Cold and Diet Medications containing Phenylpropanolamine (PPA) and Tylenol.
Michael has an AV Peer Review Rating. He has frequently lectured in the area of mass tort litigation. He was selected Pennsylvania Rising Star - Super Lawyers, in 2005 and in 2009-2012 as a Pennsylvania Super-Lawyer.